Allmed: In 2024, the net profit is 369 million yuan, a year-on-year increase of 233.95%
Allmed announced that its operating revenue for 2024 is expected to be 3.326 billion yuan, a year-on-year increase of 20.66%. The net profit attributable to shareholders of the listed company is 369 million yuan, a year-on-year increase of 233.95%. The basic earnings per share is 0.5899 yuan/share, a year-on-year increase of 238.44%. The company plans to distribute a cash dividend of 0.6 yuan for every 10 shares to all shareholders, with no bonus shares issued and no capital reserve fund converted into share capital
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments